BAY CITY CAPITAL FUND LLC Insider Trading $ILIU INTERLEUKIN GENETICS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BAY CITY CAPITAL FUND LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BAY CITY CAPITAL FUND LLC. BAY CITY CAPITAL FUND LLC is 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and Director in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and 10% Owner in SUNESIS PHARMACEUTICALS INC ($SNSS) and in NEVRO CORP ($NVRO) and 10% Owner in Epizyme, Inc. ($EPZM) and 10% Owner in Kezar Life Sciences, Inc. ($KZR) and 10% Owner in IMARA Inc. ($IMRA).

BAY CITY CAPITAL FUND LLC in INTERLEUKIN GENETICS INC

Trading Symbol: ILIU
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of BAY CITY CAPITAL FUND LLC: 10% Owner
Holdings: 75,800,716 shares
Current Value: $7,580,072
Latest Transaction: Aug 02 2016
$ILIU Market Capitalization: $22.11M
$ILIU Previous Close: $0.10

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of BAY CITY CAPITAL FUND LLC in INTERLEUKIN GENETICS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, EPZM, IMRA, ILIU, KZR, SNTA, NVRO, SNSS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 02 2016ILIUINTERLEUKIN GENETI ...BAY CITY CAPITAL LLC10% OwnerOption ExerciseP0.10564,38656,100564,386
Aug 02 2016ILIUINTERLEUKIN GENETI ...BAY CITY CAPITAL LLC10% OwnerOption ExerciseP0.1029,616,7002,943,90029,616,700
Aug 02 2016ILIUINTERLEUKIN GENETI ...BAY CITY CAPITAL LLC10% OwnerBuyP0.10564,38656,1001,444,485880.1 K to 1.4 M (+64.13 %)
Aug 02 2016ILIUINTERLEUKIN GENETI ...BAY CITY CAPITAL LLC10% OwnerBuyP0.1029,616,7002,943,90075,800,71646.2 M to 75.8 M (+64.13 %)

Page:   1